18F-NY104

N/A

Report date: 2025/10/20 14:43:33

NME

Base Information

Drug Name18F-NY104

Drug Alias NameFluorine 18-NY10418F-NY10418F-NYM005

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[4]

Mechanisms of ActionPositron-emission tomography enhancersCarbonic anhydrase IX inhibitors

TargetsCarbonic anhydrase IX

Therapy Area/IndicationsContrast agentsCarcinoma, Renal Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesWuxi Nuoyu Pharmaceutical Technology Co Ltd

China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesWuxi Nuoyu Pharmaceutical Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsContrast agentsCarcinoma, Renal Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A